Biocompatibility of MIM 316L stainless steel

Abstract

To evaluate the biocompatibility of MIM 316L stainless steel, the percentage of S-period cells were detected by flow cytometry after L929 incubated with extraction of MIM 316L stainless steel, using titanium implant materials of clinical application as the contrast. Both materials were implanted in animal and the histopathological evaluations were carried out. The statistical analyses show that there are no significant differences between two groups (P>0.05), which demonstrates that MIM 316L stainless steel has a good biocompatibility.

Keywords

316L stainless steel / metal powder injection moulding / biocompatibility / flow cytometry

References

[1] GermanR M. Technological barriers and opportunities in powder injection moulding[J]. Powder Metallurgy Int, 1993, 25(4): 165-165

[2] MerharJ R. Overview of metal injection moulding[J]. Metal Powder Report, 1990, 45(5): 339-342

[3] CacendishJ C. Integrating feature-based surface design with freeform deformation[J]. Computer Aided Design, 1995, 27(9): 703-711

[4] WalterM, OliverP, AndreasF. Special injection moulding processes in practical application[J]. Kunststoffe Plast Europe, 2000, 90(10): 20-22

[5] YuY T, ZhangX DBiomedical Materials[M], 2000, Tianjin, Tianjin University Press: 28-34(in Chinese)

[6] StivastavaS, StephenD G. Screening of in vitro cytoxicity by the adhesive test[J]. Biomaterial, 1990, 11(3): 133-133

[7] WangJ Z, WangS J. The tendency of development flow cytometry analyse at present [J]. Chin J Lab Med, 2002, 5(1): 5-7(in Chinese)